Raymond James Trust’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,824
Closed -$221K 1190
2023
Q2
$221K Hold
14,824
0.01% 1064
2023
Q1
$210K Hold
14,824
0.01% 1046
2022
Q4
$207K Hold
14,824
0.01% 1037
2022
Q3
$192K Hold
14,824
0.01% 999
2022
Q2
$199K Hold
14,824
0.01% 1013
2022
Q1
$226K Hold
14,824
0.01% 1034
2021
Q4
$237K Hold
14,824
0.01% 1014
2021
Q3
$231K Hold
14,824
0.01% 988
2021
Q2
$225K Hold
14,824
0.01% 997
2021
Q1
$206K Hold
14,824
0.01% 1023
2020
Q4
$195K Hold
14,824
0.01% 982
2020
Q3
$185K Hold
14,824
0.01% 900
2020
Q2
$199K Hold
14,824
0.01% 848
2020
Q1
$172K Hold
14,824
0.01% 737
2019
Q4
$250K Hold
14,824
0.01% 783
2019
Q3
$250K Hold
14,824
0.01% 750
2019
Q2
$232K Hold
14,824
0.01% 761
2019
Q1
$229K Buy
+14,824
New +$231K 0.01% 718

Other funds holding MCI

Raymond James Trust's MCI Position: Q3 2023 in Review

Raymond James Trust sold out of Barings Corporate Investors (MCI) in Q3 2023, closing a stake of 14,824 shares — an estimated $221K sold.

Raymond James Trust first reported a position in MCI in Q1 2019 and held it in 18 quarters. The position peaked at $250K in Q4 2019. 54 funds tracked by Wall St. Rank hold MCI as of Q3 2023.

  • Raymond James Trust reported no remaining Barings Corporate Investors position as of Q3 2023 after selling out during the quarter.
  • Raymond James Trust sold 14,824 Barings Corporate Investors shares in Q3 2023, an estimated $221K.
  • Raymond James Trust first reported a position in Barings Corporate Investors in Q1 2019 and held it in 18 quarters.
  • Raymond James Trust's Barings Corporate Investors position peaked at $250K in Q4 2019.
  • 54 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q3 2023.

Based on Raymond James Trust's 13F filing for Q3 2023, filed 14 Nov 2023.